1. null
    Yesim Gökmen-Polar et al, 2016 CrossRef
  2. ApoptomiRs of Breast Cancer: Basics to Clinics
    Shivani Sharma et al, 2016, Front. Genet. CrossRef
  3. Functional proteomics outlines the complexity of breast cancer molecular subtypes
    Angelo Gámez-Pozo et al, 2017, Sci Rep CrossRef
  4. Prognostic and predictive biomarkers in breast cancer: Past, present and future
    Andrea Nicolini et al, 2017, Seminars in Cancer Biology CrossRef
  5. Identification of miRNAs as biomarkers for acquired endocrine resistance in breast cancer
    Penn Muluhngwi et al, 2017, Molecular and Cellular Endocrinology CrossRef
  6. miR-221/222 Are Involved in Response to Sunitinib Treatment in Metastatic Renal Cell Carcinoma
    Heba W Z Khella et al, 2015, Molecular Therapy CrossRef
  7. Nuclear and extranuclear-initiated estrogen receptor signaling crosstalk and endocrine resistance in breast cancer
    Eylem Kulkoyluoglu et al, 2016, Steroids CrossRef
  8. MicroRNA-342 inhibits the progression of glioma by directly targeting PAK4
    Xianghe Lu et al, 2017 CrossRef
  9. Expression of microRNA-10a, microRNA-342-3p and their predicted target gene TIAM1 in extranodal NK/T-cell lymphoma, nasal type
    HAOBO HUANG et al, 2016 CrossRef
  10. A Potential Prognostic Long Noncoding RNA Signature to Predict Recurrence among ER-positive Breast Cancer Patients Treated with Tamoxifen
    Kang Wang et al, 2018, Sci Rep CrossRef
  11. Differential microRNA profiles between fulvestrant-resistant and tamoxifen-resistant human breast cancer cells
    Qian Zhou et al, 2018, Anti-Cancer Drugs CrossRef
  12. Estradiol and the Development of the Cerebral Cortex: An Unexpected Role?
    Matthew C. S. Denley et al, 2018, Front. Neurosci. CrossRef
  13. Cancer epigenetics: Moving forward.
    Angela Nebbioso et al, 2018, PLoS Genet CrossRef
  14. Loss of function of miR-342-3p results in MCT1 over-expression and contributes to oncogenic metabolic reprogramming in triple negative breast cancer
    Sandra L. Romero-Cordoba et al, 2018, Sci Rep CrossRef
  15. microRNA Regulation in Estrogen Receptor-Positive Breast Cancer and Endocrine Therapy
    Erin W. Howard et al, 2018, Biol Proced Online CrossRef
  16. Key microRNAs in the biology of breast cancer; emerging evidence in the last decade
    Monireh Khordadmehr et al, 2018, J Cell Physiol CrossRef
  17. Functional high-throughput screening reveals miR-323a-5p and miR-342-5p as new tumor-suppressive microRNA for neuroblastoma
    Aroa Soriano et al, 2019, Cell. Mol. Life Sci. CrossRef
  18. Recent trends in microRNA research into breast cancer with particular focus on the associations between microRNAs and intrinsic subtypes.
    Sasagu Kurozumi et al, 0 CrossRef
  19. Plasma proteomics analysis of tamoxifen resistance in breast cancer
    Keivan Majidzadeh-A et al, 2013, Med Oncol CrossRef
  20. miR-342 Regulates BRCA1 Expression through Modulation of ID4 in Breast Cancer
    Elisabetta Crippa et al, 2014, PLoS ONE CrossRef
  21. The effects of environmental chemical carcinogens on the microRNA machinery
    A. Izzotti et al, 2014, International Journal of Hygiene and Environmental Health CrossRef
  22. The role of microRNAs in human breast cancer progression
    WenCheng Zhang et al, 2014, Tumor Biol. CrossRef
  23. null
    Michael G. Schrauder et al, 2014 CrossRef
  24. Effect of a high-intensity interval training on serum microRNA levels in women with breast cancer undergoing hormone therapy. A single-blind randomized trial
    Shaban Alizadeh et al, 2019, Annals of Physical and Rehabilitation Medicine CrossRef
  25. Tamoxifen resistance: From cell culture experiments towards novel biomarkers
    Norbert Nass et al, 2015, Pathology - Research and Practice CrossRef
  26. miR-342-3p targets RAP2B to suppress proliferation and invasion of non-small cell lung cancer cells
    Xiao Xie et al, 2015, Tumor Biol. CrossRef
  27. Dysregulation of microRNAs in breast cancer and their potential role as prognostic and predictive biomarkers in patient management.
    Eleni van Schooneveld et al, 0 CrossRef
  28. MicroRNA: a connecting road between apoptosis and cholesterol metabolism
    Yogita K. Adlakha et al, 2016, Tumor Biol. CrossRef
  29. Decoding the usefulness of non-coding RNAs as breast cancer markers
    Maria Amorim et al, 2016, J Transl Med CrossRef
  30. MicroRNA-328 is involved in wound repair process in human bronchial epithelial cells
    Beata Narożna et al, 2017, Respiratory Physiology & Neurobiology CrossRef
  31. Emerging therapies for breast cancer
    Xichun Hu et al, 2017, J Hematol Oncol CrossRef
  32. Differential expression of the miR-17-92 cluster and miR-17 family in breast cancer according to tumor type; results from the Norwegian Women and Cancer (NOWAC) study
    Line Moi et al, 2019, J Transl Med CrossRef
  33. Oestrogen receptor negativity in breast cancer: a cause or consequence?
    Vijaya Narasihma Reddy Gajulapalli et al, 2016 CrossRef
  34. miR-342 overexpression results in a synthetic lethal phenotype in BRCA1-mutant HCC1937 breast cancer cells
    Elisabetta Crippa et al, 2016, Oncotarget CrossRef
  35. Tamoxifen sensitivity-related microRNA-342 is a useful biomarker for breast cancer survival
    Jessica Young et al, 2017, Oncotarget CrossRef
  36. Dissecting miRNA facilitated physiology and function in human breast cancer for therapeutic intervention
    Dipta Sengupta et al, 2020, Seminars in Cancer Biology CrossRef
  37. miRNA profile obtained by next‑generation sequencing in metastatic breast cancer patients is able to predict the response to systemic treatments
    Antonio Martinez‑Gutierrez et al, 2019, Int J Mol Med CrossRef
  38. MicroRNA‑342 inhibits cell proliferation and invasion in nasopharyngeal carcinoma by directly targeting ZEB1
    Xiaoning Zhu et al, 2018, Oncol Lett CrossRef
  39. Machine Learning-Based Ensemble Recursive Feature Selection of Circulating miRNAs for Cancer Tumor Classification
    Alejandro Lopez-Rincon et al, 2020, Cancers CrossRef
  40. CD63 + Cancer‐Associated Fibroblasts Confer Tamoxifen Resistance to Breast Cancer Cells through Exosomal miR‐22
    Yuan Gao et al, 2020, Adv. Sci. CrossRef
  41. Combined Label-Free Quantitative Proteomics and microRNA Expression Analysis of Breast Cancer Unravel Molecular Differences with Clinical Implications
    Angelo Gámez-Pozo et al, 2015, Cancer Res CrossRef
  42. MicroRNAs Involved in Inflammatory Breast Cancer: Oncogene and Tumor Suppressors with Possible Targets
    Zohreh Rezaei et al, 2021, DNA and Cell Biology CrossRef
  43. Increased expression of MUSASHI1 in epithelial breast cancer cells is due to down regulation of miR-125b.
    Mahboobeh Forouzanfar et al, 2021, BMC Mol Cell Biol CrossRef
  44. Evaluation of miRNAs 9 and 342 expressions in sera as diagnostic and prognostic biomarkers for breast cancer
    Heba A. Ewida et al, 2021, BD CrossRef
  45. MicroRNAs as a clue to overcome breast cancer treatment resistance
    Iris Garrido-Cano et al, 2021, Cancer Metastasis Rev CrossRef
  46. Chemoresistance mechanisms of breast cancer and their countermeasures
    Xiwei Ji et al, 2019, Biomedicine & Pharmacotherapy CrossRef
  47. Towards Unravelling the Role of ERα-Targeting miRNAs in the Exosome-Mediated Transferring of the Hormone Resistance
    Olga E. Andreeva et al, 2021, Molecules CrossRef
  48. Associations between the Levels of Estradiol-, Progesterone-, and Testosterone-Sensitive MiRNAs and Main Clinicopathologic Features of Breast Cancer
    Tatiana Kalinina et al, 2021, JPM CrossRef
  49. Exosomal telomerase transcripts reprogram the microRNA transcriptome profile of fibroblasts and partially contribute to CAF formation
    Daniela Likonen et al, 2022, Sci Rep CrossRef
  50. Molecular Mechanisms of Anti-Estrogen Therapy Resistance and Novel Targeted Therapies
    Rumeysa Ozyurt et al, 2022, Cancers CrossRef
  51. null
    Md Abdus Subhan, 2023 CrossRef
  52. Non-Coding RNAs Modulating Estrogen Signaling and Response to Endocrine Therapy in Breast Cancer
    Oliver Treeck et al, 2023, Cancers CrossRef
  53. The impact of miRNAs on the efficacy of Tamoxifen in breast cancer treatment.: A systematic review
    Nima Nikbin Kavishahi et al, 2024, Clinical Breast Cancer CrossRef
  54. null
    Zuzana Kos et al, 2017 CrossRef